Pillars

Editas Medicine (NASDAQ:) has reported significant strides in its first quarter of 2024, focusing on delivering innovative treatments for genetic diseases. The company emphasized its strategy, which includes advancing its gene editing…

As the new year approaches, it is possible to make educated predictions about what the financial landscape will look like in the coming year and possibly beyond. Although everyone has their own opinion, most banking and financial experts…